AstraZeneca investing $2.5bn in China as drugmaker seeks to recover from scandals
LONDON: AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the ...
Read moreTag: AstraZeneca
Popular Post
FRSHAR Mail set to redefine secure communication, data privacy
How to avoid buyer’s remorse when raising venture capital
Microsoft to pay off cloud industry group to end EU antitrust complaint
Capacity utilisation of Pakistan’s cement industry drops to lowest on record
SingTel annual profit more than halves on $2.3bn impairment charge
American Dollar Exchange Rate